Natasha Fillmore

2.1k total citations
32 papers, 1.6k citations indexed

About

Natasha Fillmore is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Natasha Fillmore has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Physiology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Natasha Fillmore's work include Adipose Tissue and Metabolism (17 papers), Metabolism, Diabetes, and Cancer (11 papers) and Cardiovascular Function and Risk Factors (9 papers). Natasha Fillmore is often cited by papers focused on Adipose Tissue and Metabolism (17 papers), Metabolism, Diabetes, and Cancer (11 papers) and Cardiovascular Function and Risk Factors (9 papers). Natasha Fillmore collaborates with scholars based in United States, Canada and Qatar. Natasha Fillmore's co-authors include Gary D. Lopaschuk, Jun Mori, David M. Thomson, W. W. Winder, Cory S. Wagg, Jagdip S. Jaswal, Jonathan D. Brown, Arata Fukushima, Hoon Kim and Seth T. Herway and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Diabetes.

In The Last Decade

Natasha Fillmore

32 papers receiving 1.6k citations

Peers

Natasha Fillmore
Ola J. Martin United States
Christian Riehle United States
Sandra Sena United States
Satoru Tatematsu Japan
Stephen P. Gray Australia
Shudong Wang China
Nathan D. Roe United States
Kazuhiro Sonoda Japan
Heather Theobald United States
Anna Planavila Spain
Ola J. Martin United States
Natasha Fillmore
Citations per year, relative to Natasha Fillmore Natasha Fillmore (= 1×) peers Ola J. Martin

Countries citing papers authored by Natasha Fillmore

Since Specialization
Citations

This map shows the geographic impact of Natasha Fillmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Fillmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Fillmore more than expected).

Fields of papers citing papers by Natasha Fillmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Fillmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Fillmore. The network helps show where Natasha Fillmore may publish in the future.

Co-authorship network of co-authors of Natasha Fillmore

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Fillmore. A scholar is included among the top collaborators of Natasha Fillmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Fillmore. Natasha Fillmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gasparotto, Arquimedes, et al.. (2024). Cardiovascular-kidney-metabolic syndrome – An integrative review. Progress in Cardiovascular Diseases. 87. 26–36. 24 indexed citations
2.
Fillmore, Natasha, et al.. (2024). Dual-edged role of SIRT1 in energy metabolism and cardiovascular disease. American Journal of Physiology-Heart and Circulatory Physiology. 327(5). H1162–H1173. 6 indexed citations
3.
Fillmore, Natasha, Junhui Sun, Audrey Noguchi, et al.. (2019). A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release. Journal of Molecular and Cellular Cardiology. 136. 95–101. 7 indexed citations
4.
Fillmore, Natasha, Jody Levasseur, Arata Fukushima, et al.. (2018). Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. Molecular Medicine. 24(1). 3–3. 90 indexed citations
5.
Fillmore, Natasha, Cory S. Wagg, Liyan Zhang, Arata Fukushima, & Gary D. Lopaschuk. (2018). Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart. American Journal of Physiology-Endocrinology and Metabolism. 315(5). E1046–E1052. 56 indexed citations
6.
Ussher, John R., Natasha Fillmore, Wendy Keung, et al.. (2016). Genetic and Pharmacological Inhibition of Malonyl CoA Decarboxylase Does Not Exacerbate Age-Related Insulin Resistance in Mice. Diabetes. 65(7). 1883–1891. 11 indexed citations
7.
Gadeau, Alain‐Pierre, Larry Fliegel, Gary D. Lopaschuk, et al.. (2015). Na+/H+ Exchanger Isoform 1-Induced Osteopontin Expression Facilitates Cardiomyocyte Hypertrophy. PLoS ONE. 10(4). e0123318–e0123318. 15 indexed citations
8.
Fillmore, Natasha, Wendy Keung, Sandra Kelly, et al.. (2015). Accumulation of ceramide in slow‐twitch muscle contributes to the development of insulin resistance in the obese JCR:LA‐cp rat. Experimental Physiology. 100(6). 730–741. 10 indexed citations
9.
Alrob, Osama Abo, Sowndramalingam Sankaralingam, Cary Ma, et al.. (2014). Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovascular Research. 103(4). 485–497. 176 indexed citations
10.
Ussher, John R., Wendy Keung, Natasha Fillmore, et al.. (2014). Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice. Journal of Pharmacology and Experimental Therapeutics. 349(3). 487–496. 18 indexed citations
11.
Ussher, John R., Natasha Fillmore, Wendy Keung, et al.. (2014). Trimetazidine Therapy Prevents Obesity-Induced Cardiomyopathy in Mice. Canadian Journal of Cardiology. 30(8). 940–944. 28 indexed citations
12.
Henriksen, Bradley S., et al.. (2013). The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding. Diabetology & Metabolic Syndrome. 5(1). 29–29. 42 indexed citations
13.
Fillmore, Natasha, Jun Mori, & Gary D. Lopaschuk. (2013). Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. British Journal of Pharmacology. 171(8). 2080–2090. 355 indexed citations
14.
Fillmore, Natasha & Gary D. Lopaschuk. (2012). Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(4). 857–865. 113 indexed citations
15.
Ussher, John R., Clifford D.L. Folmes, Wendy Keung, et al.. (2012). Inhibition of Serine Palmitoyl Transferase I Reduces Cardiac Ceramide Levels and Increases Glycolysis Rates following Diet-Induced Insulin Resistance. PLoS ONE. 7(5). e37703–e37703. 39 indexed citations
16.
Thomson, David M., Chad R. Hancock, Jacob D. Brown, et al.. (2010). Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice. Journal of Applied Physiology. 108(6). 1775–1785. 40 indexed citations
17.
Thomson, David M., Jacob D. Brown, Natasha Fillmore, et al.. (2009). AMP‐activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle. The Journal of Physiology. 587(9). 2077–2086. 31 indexed citations
18.
Kim, Hyung Jun, Natasha Fillmore, Jonathan D. Brown, et al.. (2008). Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1α in rat muscle. Journal of Applied Physiology. 105(4). 1218–1227. 42 indexed citations
19.
Thomson, David M., Jacob D. Brown, Natasha Fillmore, et al.. (2007). LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle. American Journal of Physiology-Endocrinology and Metabolism. 293(6). E1572–E1579. 52 indexed citations
20.
Thomson, David M., Seth T. Herway, Natasha Fillmore, et al.. (2007). AMP-activated protein kinase phosphorylates transcription factors of the CREB family. Journal of Applied Physiology. 104(2). 429–438. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ola J. Martin Breakdown of academic impact, for papers by Christian Riehle Breakdown of academic impact, for papers by Sandra Sena Breakdown of academic impact, for papers by Satoru Tatematsu Breakdown of academic impact, for papers by Stephen P. Gray Breakdown of academic impact, for papers by Shudong Wang Breakdown of academic impact, for papers by Nathan D. Roe Breakdown of academic impact, for papers by Kazuhiro Sonoda Breakdown of academic impact, for papers by Heather Theobald Breakdown of academic impact, for papers by Anna Planavila
Rankless by CCL
2026